Considerations for an in Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00934
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 29, 2019
Authors
Publisher
Frontiers Media SA